Point-Of-Care Chemistry Test (POCT) Effect on the Emergency Department (ED)

This study has been completed.
Information provided by:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
First received: July 20, 2009
Last updated: NA
Last verified: July 2009
History: No changes posted
The hypothesis of this study is that POCT will shorten ED turn-around-time (TAT) such as blood drawing TAT, lab TAT, and decision TAT.

Emergency Department
Length of Stay

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: A Randomized Controlled Multi-center Trial of a Point-Of-Care Chemistry Test for Reduction of Turnaround and Clinical Decision Time in the Emergency Department

Further study details as provided by Seoul National University Hospital:

Study Start Date: January 2009
Study Completion Date: March 2009
Primary Completion Date: March 2009 (Final data collection date for primary outcome measure)
The patients whose blood are analyzed by conventional central laboratory.
the patients group whose lab analyze by POCT device.


Ages Eligible for Study:   15 Years and older
Genders Eligible for Study:   Both
Sampling Method:   Probability Sample
Study Population
This study was performed in five EDs. Three were urban EDs with 30,000 to 45,000 annual visits, and two were suburban EDs with 15,000 to 25,000 annual visits. Each hospital has its own central laboratory which can test the same emergency chemistry tests, including liver panel (alkaline phosphatase, protein, albumin, total bilirubin, direct bilirubin, GOT, and GPT), renal panel (BUN, creatinine, calcium, and phosphorus), pancreas enzymes (amylase, lipase), electrolytes (sodium, potassium, chloride, total CO2), lipid panel (total cholesterol, triglyceride, LDL-cholesterol, HDL-cholesterol), and blood gases (pH, pO2, pCO2, and bicarbonate).

Inclusion Criteria:

  • Patients older than 15 years
  • clinically required to have chemistry lab tests
  • agreement

Exclusion Criteria:

  • no agreement
  • ESI level 1
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Shin Sang Do/Assistant professor, Seoul National University Hospital Department of Emergency medicine
ClinicalTrials.gov Identifier: NCT00942955     History of Changes
Other Study ID Numbers: SNUEMS200801
Study First Received: July 20, 2009
Last Updated: July 20, 2009
Health Authority: Korea: Ministry for Health and Welfare

Additional relevant MeSH terms:
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on November 30, 2015